Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 236.89M P/E - EPS this Y 14.70% Ern Qtrly Grth -
Income -46.66M Forward P/E -6.06 EPS next Y 31.00% 50D Avg Chg -6.00%
Sales 58.45M PEG - EPS past 5Y - 200D Avg Chg -4.00%
Dividend N/A Price/Book 59.45 EPS next 5Y - 52W High Chg -26.00%
Recommedations 1.80 Quick Ratio 3.33 Shares Outstanding 24.65M 52W Low Chg 51.00%
Insider Own 2.54% ROA -37.76% Shares Float 15.79M Beta 0.95
Inst Own 86.82% ROE -281.23% Shares Shorted/Prior 0.93M/719.61K Price 9.69
Gross Margin 69.27% Profit Margin -79.83% Avg. Volume 124,648 Target Price 14.60
Oper. Margin -72.23% Earnings Date May 9 Volume 97,617 Change -4.53%
About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

TELA Bio, Inc. News
04/25/24 TELA Bio to Announce First Quarter 2024 Financial Results
04/15/24 TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
04/10/24 Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?
04/08/24 TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
03/24/24 Analysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Results
03/23/24 TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)
03/22/24 TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript
03/22/24 Q4 2023 TELA Bio Inc Earnings Call
03/21/24 TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023
03/21/24 TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates
03/21/24 TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
03/21/24 TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
03/20/24 TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
03/20/24 MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
02/29/24 TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
02/28/24 Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains?
02/23/24 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/17/24 With 54% institutional ownership, TELA Bio, Inc. (NASDAQ:TELA) is a favorite amongst the big guns
12/05/23 TELA Bio to Take Part in Connecting the Dots
11/16/23 TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
TELA Chatroom

User Image Stock_Titan Posted - 2 days ago

$TELA TELA Bio to Announce First Quarter 2024 Financial Results https://www.stocktitan.net/news/TELA/tela-bio-to-announce-first-quarter-2024-financial-0pbor02k0xn8.html

User Image Chillen45 Posted - 5 days ago

$TELA $SPY just a week ago Bill Baruchi said under $150 I’m done buying Tesla. Now he is buying more.. lol crazy emotions. Epitome of the market all chase

User Image ICU2025 Posted - 1 week ago

$RMTI Its so interesting if you compare Rockwell to $TELA Both niche products TELA market cap $120 million losing about 30 million a year on sales of $70 million RMTI market $45 million breaking even sales around $88 million TELA is $4.75 RMTI $1.45

User Image pie_make_it Posted - 1 week ago

$AMD both amd and $TELA 150$!!

User Image OpenOutcrier Posted - 1 week ago

$TELA (+5.5% pre) TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures - SI https://ooc.bz/l/30349

User Image Stock_Titan Posted - 1 week ago

$TELA TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures https://www.stocktitan.net/news/TELA/tela-bio-announces-u-s-commercial-launch-of-robotic-compatible-ovi-pgn77910pa4p.html

User Image Stock_Titan Posted - 2 weeks ago

$TELA TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy https://www.stocktitan.net/news/TELA/tela-bio-welcomes-acclaimed-surgeon-as-vice-president-of-medical-5lqc4x65w0e9.html

User Image erevnon Posted - 1 month ago

Piper Sandler maintains TELA Bio $TELA at Overweight and lowers the price target from $15 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image RocketThief Posted - 1 month ago

$TELA I like what I’m seeing here - strong growth continuing, cash to profitability, focus on the core product. Right around my cost basis now but will add heavily in the event of a market-driven dip

User Image AnaChart Posted - 1 month ago

$TELA https://anachart.com/wp-content/uploads/ana_temp/1711119709_soc-img.jpg

User Image DonCorleone77 Posted - 1 month ago

$TELA TELA Bio reports Q4 EPS (53c), consensus (43c) Reports Q4 revenue $17M, consensus $16.39M. "Our team has executed on our initiatives to drive market penetration, resulting in yet another year with over 40% year-over-year growth," said Antony Koblish, co-founder, President, and Chief Executive Officer of TELA Bio. "The recalibration of our sales force over 2023 has led to increased productivity and an improved mix of sales across our product portfolio. At this week's National Sales Meeting, we were thrilled to announce the formal launch of the LIQUIFIX devices, which we believe advances the future of hernia repair fixation in robotic, laparoscopic, and open cases with it novel, atraumatic approach. Beyond LIQUIFIX, the upcoming launch of our OviTex IHR suite of products should drive deeper penetration into the inguinal hernia space, generating greater awareness and adoption of products across our entire hernia franchise...."

User Image Stock_Titan Posted - 1 month ago

$TELA TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results https://www.stocktitan.net/news/TELA/tela-bio-achieves-record-fourth-quarter-and-full-year-2023-revenues-hc2uou5h06f9.html

User Image OpenOutcrier Posted - 1 month ago

$TELA (+5.8% pre) TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery https://ooc.bz/l/28315

User Image Stock_Titan Posted - 1 month ago

$TELA TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery https://www.stocktitan.net/news/TELA/tela-bio-announces-u-s-commercial-launch-of-liquifix-the-only-fda-hlsiu3gp5vf7.html

User Image RocketThief Posted - 1 month ago

$TELA nice way to tighten up the balance sheet

User Image Stock_Titan Posted - 1 month ago

$TELA TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX https://www.stocktitan.net/news/TELA/tela-bio-announces-sale-of-distribution-rights-for-wound-care-ocuf6vq3fers.html

User Image USMA67Korea Posted - 1 month ago

$TELA MC at $120M or so for $75M 2024 sales. P/S, EV, etc. all cheap. will need to raise later though (hopefully one last time). but ceo needs to deliver. he has missed 3 out of last 4 revenue forecasts. sales turnover was latest reason. but cannot keep making excuses

User Image RocketThief Posted - 1 month ago

$TELA nibbled, a little nervous about earnings but this is a low volume drop

User Image Dubbld Posted - 1 month ago

$TELA March 21, going to be ⚡️ 🔥!

User Image Stock_Titan Posted - 02/29/24

$TELA TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/TELA/tela-bio-to-announce-fourth-quarter-and-full-year-2023-financial-ueyk1c1jqmj7.html

User Image RainbowTrump Posted - 02/28/24

$TELA sudden spike in volume. Price action is shit. Where the heck are earnings?

User Image TickerDD_com Posted - 2 months ago

From 2/14/2024, looking back across 22 Month-Ends for TELA, Percentage Change of Average Monthly Price had More Positives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $TELA #TELA #TELAStock #TickerDD #TELAPrice https://www.youtube.com/watch?v=NVkBFzRtiZI

User Image Dubbld Posted - 2 months ago

$TELA earnings are going to be wild here, $8.50-9+ after ER, mark this post

User Image Stock_Titan Posted - 2 months ago

$TELA TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/TELA/tela-bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-4nigsrb4tb4s.html

User Image RainbowTrump Posted - 2 months ago

$TELA feels very overdue for earnings

User Image DefenseMania Posted - 2 months ago

I found this on NewsBreak: I rented an EV from Hertz. I'm not surprised they're dumping 20,000 electric cars. $TELA $F $TM https://share.newsbreak.com/67letl13

User Image insiderbuyingselling Posted - 2 months ago

$TELA new insider buying: 326062 shares. http://insiderbuyingselling.com/?t=TELA

User Image Muhib786 Posted - 2 months ago

$LCID $TELA https://www.motortrend.com/reviews/2022-lucid-air-grand-touring-performance-yearlong-review-update-2-tesla-model-s-plaid-quality-comparison/

User Image Dubbld Posted - 2 months ago

$TELA when is earnings?? Going to be 🔥, this company is gobbling up market space up rapidly! I haven’t heard of a hotter mesh tech manufacturer amongst ORs when checking in from hospital to hospital.

User Image RocketThief Posted - 3 months ago

$TELA looking forward to the next irrational Medtech crash

Analyst Ratings
JMP Securities Market Outperform Mar 22, 24
Piper Sandler Overweight Mar 22, 24
Lake Street Buy Dec 27, 23
JMP Securities Market Outperform Nov 10, 23
Canaccord Genuity Buy Mar 28, 23
JMP Securities Market Outperform Mar 22, 23
JMP Securities Market Outperform Nov 10, 22
Piper Sandler Overweight Nov 10, 22
Piper Sandler Overweight Aug 13, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Cuca Roberto COO and CFO COO and CFO Nov 14 Buy 4.4938 10,000 44,938 62,371 11/14/23
KOBLISH ANTONY Chief Executive Offi.. Chief Executive Officer Nov 14 Buy 4.5433 11,000 49,976 303,634 11/14/23
ORBIMED ADVISORS LLC 10% Owner 10% Owner Apr 19 Sell 9.38 192,000 1,800,960 2,835,542 04/21/23
Burgess Vincent J Director Director Mar 29 Option 4.44 4,860 21,578 7,995 03/31/23
Opaleye Management Inc. 10% Owner 10% Owner Sep 13 Buy 8.1 5,221 42,290 120,217 09/15/22
Opaleye Management Inc. 10% Owner 10% Owner Aug 01 Buy 7.96 4,979 39,633 100,679 08/12/22
Opaleye Management Inc. 10% Owner 10% Owner Aug 10 Buy 8.52 11,979 102,061 105,000 08/12/22
Opaleye Management Inc. 10% Owner 10% Owner Jul 22 Buy 8.02 5,200 41,704 100,200 07/22/22
Opaleye Management Inc. 10% Owner 10% Owner Jul 21 Buy 8.05 10,333 83,181 100,000 07/21/22
Opaleye Management Inc. 10% Owner 10% Owner Jul 20 Buy 8.08 5,100 41,208 99,167 07/20/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jul 11 Buy 8.02 15,000 120,300 3,605,709 07/13/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jul 06 Buy 7.96 15,000 119,400 3,590,709 07/08/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jun 30 Buy 7.29 15,000 109,350 3,575,709 07/05/22
Opaleye Management Inc. 10% Owner 10% Owner Jul 01 Buy 7.00 200 1,400 98,567 07/05/22
Opaleye Management Inc. 10% Owner 10% Owner Jun 29 Buy 7 3,567 24,969 98,367 06/30/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jun 27 Buy 7.14 15,000 107,100 3,560,709 06/29/22
Opaleye Management Inc. 10% Owner 10% Owner Jun 24 Buy 6.99 2,400 16,776 97,800 06/24/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jun 22 Buy 6.84 15,000 102,600 3,545,709 06/24/22
Opaleye Management Inc. 10% Owner 10% Owner Jun 22 Buy 6.5 52,400 340,600 97,400 06/22/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jun 16 Buy 6.14 15,000 92,100 3,530,709 06/21/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jun 13 Buy 5.86 15,000 87,900 3,515,709 06/15/22
Opaleye Management Inc. 10% Owner 10% Owner Jun 10 Buy 5.6 27,500 154,000 95,000 06/10/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jun 08 Buy 5.98 15,000 89,700 3,500,709 06/10/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jun 03 Buy 6.13 15,000 91,950 3,485,709 06/07/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 31 Buy 6.99 15,000 104,850 3,470,709 06/02/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 25 Buy 7.11 15,000 106,650 3,455,709 05/27/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 20 Buy 8.17 15,000 122,550 3,440,709 05/24/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 17 Buy 8.96 15,000 134,400 3,425,709 05/19/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 12 Buy 8.43 15,000 126,450 3,410,709 05/16/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 09 Buy 9.16 15,000 137,400 3,395,709 05/11/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 05 Buy 9.59 10,000 95,900 3,380,709 05/09/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other May 02 Buy 9.42 15,000 141,300 3,370,709 05/04/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Apr 27 Buy 9.1 15,000 136,500 3,355,709 04/29/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Apr 25 Buy 9.37 15,000 140,550 3,340,709 04/27/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Apr 14 Buy 9.88 8,789 86,835 3,325,709 04/19/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Mar 31 Buy 11.5 5,684 65,366 3,316,920 04/04/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Mar 29 Buy 11.65 5,697 66,370 3,311,236 03/31/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Mar 22 Buy 11.65 136 1,584 3,305,539 03/24/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Mar 16 Buy 11.66 5,904 68,841 3,305,403 03/16/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Feb 22 Buy 11.74 759,808 8,920,146 3,299,499 02/24/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Feb 16 Buy 11.73 19,330 226,741 2,539,691 02/18/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Feb 08 Buy 11.75 1,827 21,467 2,512,720 02/10/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jan 28 Buy 11.54 6,950 80,203 2,510,893 02/01/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jan 26 Buy 11.63 9,993 116,219 2,503,943 01/28/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jan 24 Buy 11.8 8,846 104,383 2,493,950 01/26/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jan 14 Buy 12.00 567,467 6,809,604 2,485,104 01/19/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jan 12 Buy 12.50 5,000 62,500 1,917,637 01/14/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Jan 10 Buy 12.42 6,409 79,600 1,912,637 01/12/22
EW HEALTHCARE PARTNERS FUND 2,... Other Other Dec 15 Buy 12.44 10,050 125,022 1,896,000 12/17/21
EW HEALTHCARE PARTNERS FUND 2,... Other Other Dec 10 Buy 12.41 11,387 141,313 1,885,950 12/14/21